T86.0
Conditions
Interventions
Group 1: gene variant
Group 2: wildtype
Sponsors
Klinik für KMT
Uniklinik Essen
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: all patients who give the written consens to the study only allogeneic transplanted patients patients who did received a Tcell repleted transplant
Exclusion criteria
Exclusion criteria: HLA non identical transplants
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| grade of acute GVHD day 100 post transplant and overall survival at 1 year post transplant | — |
Secondary
| Measure | Time frame |
|---|---|
| relapse incidence 1 year post transplant | — |
Countries
Germany
Contacts
Public ContactAhmet Elmaagacli
Klinik für KMT Uniklinik Essen
Outcome results
None listed